Cargando…

Economic Evaluation of a Pharmacogenomics Test for Statin-Induced Myopathy in Cardiovascular High-Risk Patients Initiating a Statin

BACKGROUND: Statins are the mainstay hypercholesterolemia treatment and reduce the risk of cardiovascular events in patients. However, statin therapy is often interrupted in patients experiencing musculoskeletal pain or myopathy, which are common in this patient group. Currently, the standard tests...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mitchell, Dominic, Guertin, Jason R., Iliza, Ange Christelle, Fanton-Aita, Fiorella, LeLorier, Jacques
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2016
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5250641/ https://www.ncbi.nlm.nih.gov/pubmed/27798813 http://dx.doi.org/10.1007/s40291-016-0238-8

Ejemplares similares

Bias within economic evaluations – the impact of considering the future entry of lower-cost generics on currently estimated incremental cost-effectiveness ratios of a new drug
por: Guertin, Jason R, et al.
Publicado: (2015)

Cost-Effectiveness Analysis of Fosfomycin for Treatment of Uncomplicated Urinary Tract Infections in Ontario
por: Perrault, Louise, et al.
Publicado: (2017)

Pharmacogenomic insights into treatment and management of statin-induced myopathy
por: Peters, Bas JM, et al.
Publicado: (2009)

Statin-induced Myopathy
por: Fitzgerald, Kara, et al.
Publicado: (2012)

Management of statin myopathy
por: Finsterer, Josef, et al.
Publicado: (2017)

Performance of the high-dimensional propensity score in adjusting for unmeasured confounders
por: Guertin, Jason R, et al.
Publicado: (2016)

Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencing
por: Floyd, James S., et al.
Publicado: (2019)

Statin-Induced Autoimmune Myopathy
por: Nemati, Maryam, et al.
Publicado: (2021)

A multistate transition model for statin‐induced myopathy and statin discontinuation
por: Zhu, Yuxi, et al.
Publicado: (2021)

Head to head comparison of the propensity score and the high-dimensional propensity score matching methods
por: Guertin, Jason R., et al.
Publicado: (2016)

Pharmacogenomics of statins: understanding susceptibility to adverse effects
por: Kitzmiller, Joseph P, et al.
Publicado: (2016)

Statin-Induced Necrotizing Autoimmune Myopathy
por: Gawey, Brent, et al.
Publicado: (2020)

Statin-Induced Autoimmune Necrotizing Myopathy
por: Jayatilaka, Sahani, et al.
Publicado: (2021)

A statin-dependent QTL for GATM expression is associated with statin-induced myopathy
por: Mangravite, Lara M., et al.
Publicado: (2013)

Cost effectiveness of ‘on demand’ HIV pre-exposure prophylaxis for non-injection drug-using men who have sex with men in Canada
por: Ouellet, Estelle, et al.
Publicado: (2015)

Statin-induced myopathy: a case report
por: De Cock, Emmanuel, et al.
Publicado: (2018)

A Mechanism for Statin-Induced Susceptibility to Myopathy
por: Lotteau, Sabine, et al.
Publicado: (2019)

A Case of Statin-Associated Autoimmune Myopathy
por: Sweidan, Alexander J, et al.
Publicado: (2017)

Creatine, guanidinoacetate and homoarginine in statin-induced myopathy
por: Neu, Axel, et al.
Publicado: (2020)

Statin-Associated Autoimmune Myopathy: Current Perspectives
por: Tiniakou, Eleni
Publicado: (2020)

Creatine as a Candidate to Prevent Statin Myopathy
por: Balestrino, Maurizio, et al.
Publicado: (2019)

Challenges in Treating Statin-Associated Necrotizing Myopathy
por: Webster, Patrick, et al.
Publicado: (2021)

Correlates of Myopathy in Diabetic Patients Taking Statins
por: Tariq, Sara, et al.
Publicado: (2023)

Statin-induced necrotizing autoimmune myopathy: an extremely rare adverse effect from statin use
por: Sharma, Priyadarshani, et al.
Publicado: (2019)

Pharmacogenomics of response to statin treatment and susceptibility to statin-induced adverse drug reactions in Asians: a scoping review
por: Yow, Hui-Yin, et al.
Publicado: (2023)

Statin-Induced Immune-Mediated Necrotizing Myopathy: An Increasingly Recognized Inflammatory Myopathy
por: Stroie, Oana P, et al.
Publicado: (2020)

Statin therapy, myopathy and exercise--a case report
por: Semple, Stuart J
Publicado: (2012)

Statin-induced Myopathy in Skeletal Muscle: the Role of Exercise
por: Kwak, Hyo-Bum
Publicado: (2014)

Autoimmune statin-induced myopathy: a case report
por: Young, Jonathan B., et al.
Publicado: (2015)

The Impact of Exercise on Statin-Associated Skeletal Muscle Myopathy
por: Chung, Hae R., et al.
Publicado: (2016)

Impact of vitamin D status on statin-induced myopathy
por: Riche, Krista D., et al.
Publicado: (2016)

Immune-mediated necrotizing myopathy due to statins exposure
por: VILLA, LUISA, et al.
Publicado: (2018)

Statin-Associated Necrotizing Myopathy: A Feared Complication
por: Nguyen, Suong, et al.
Publicado: (2020)

Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy
por: Vinci, Pierandrea, et al.
Publicado: (2021)

Two Cases of Statin Induced Necrotizing Autoimmune Myopathy
por: Alam, Mustafa, et al.
Publicado: (2021)

Pharmacogenomic Study of Statin-Associated Muscle Symptoms in the ODYSSEY OUTCOMES Trial
por: Murphy, William A., et al.
Publicado: (2022)

STATIN INDUCED NECROTIZING AUTOIMMUNE MYOPATHY WITHOUT CONCURRENT STATIN USE: YET ANOTHER SEQUELA OF COVID-19?
por: Jaffry, Hassam, et al.
Publicado: (2022)

SLCO1B1 Polymorphisms and Statin-Induced Myopathy
por: Stewart, Alison
Publicado: (2013)

Impact of pharmacogenetics on statin-induced myopathy in South-Indian subjects
por: Ramakumari, Nuthalapati, et al.
Publicado: (2018)

Treatment of Statin-Induced Necrotizing Autoimmune Myopathy With Glucocorticoid Monotherapy
por: Lempel, Matthew, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dmlb9vj5cfdl1mh3utnr6n33mf